h.almeida
TL2 Member · Augsburg, DE
UK-based. Mostly the access and pricing categories.
Joined 18 October 2024 · last posted 2d · groups: regional-uk
92Posts here
2Topics
0Solutions
245Likes received
159Likes given
22Badges
130Days visited
1.1kPosts read
Stated areas
Recent activity
Full stream-
Sleep quality changes during weight loss Replied, post #30 · Wellbeing › Sleep · 26 Jul 2026 · 0 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #96 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 2 likes Worth separating two things that post #92 runs together. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #83 · Access › Insurance & coverage · 19 Jul 2026 · 21 likes Coming back to post #81, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 19 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
What a certificate commits its issuer to Replied, post #41 · Analytics › COA interpretation · 16 Jul 2026 · 16 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #48 · Practice › Interactions · 15 Jul 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #9 · Compounds › Repair & healing peptides · 1 Jul 2026 · 29 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #66 · Compounds › Oral incretins · 29 Jun 2026 · 3 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #44 · Sourcing › Independent verification · 26 Jun 2026 · 7 likes Worth separating two things that post #40 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Conditions that change the calculus rather than forbidding it Replied, post #24 · Safety › Contraindications · 22 Jun 2026 · 3 likes This follows post #21 rather than contradicting it. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning…
-
Private prescribing in the UK: what is actually involved Replied, post #37 · Regional › UK & Ireland · 13 Jun 2026 · 11 likes On post #33 — agreed on the reasoning, with one qualification. Regional variation in NHS: access varies dramatically by region depending on local commissioning…
-
Racemisation and why it is invisible to a mass measurement Replied, post #34 · Analytics › Impurities & related substances · 10 Jun 2026 · 1 like Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.